Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (321-330 of 632) with videos related to

Pageof 64
Sort By:
European Journal of Radiology|March 7, 2025
Hepatobiliary phase MRI-guided radiofrequency ablation of small hepatocellular carcinomas invisible on precontrast MRISebastian Ebel, Harald Busse, Anne Beeskow, et al.
Ultrasound in Medicine & Biology|May 4, 2026
Analysis of B-Scan Ultrasonography Using Neural Networks to Predict Risk of Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Josefine Stansch, Kien Vu Trung, Valentin Blank, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 16, 2003
CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophiliaHermann E Wasmuth, Alexa Werth, Tobias Mueller, et al.
The American Journal of Gastroenterology|June 28, 2019
Iberogast-Induced Acute Liver Failure-Reexposure and In Vitro Assay Support CausalityFlorian Gerhardt, Andreas Benesic, Hans L Tillmann, et al.
Journal of Gastroenterology|September 14, 2011
The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infectionViola Weich, Eva Herrmann, Tje Lin Chung, et al.
BMC Cancer|March 10, 2012
TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patientsChristian Körner, Katarina Riesner, Benjamin Krämer, et al.
Transplantation|October 5, 2002
Distinct enzyme profiles in patients with cryptogenic cirrhosis reflect heterogeneous causes with different outcomes after liver transplantation (OLT): a long-term documentation before and after OLTThomas Berg, Ruth Neuhaus, Reinhild Klein, et al.
Journal of Hepatology|December 17, 2008
A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infectionMarie-Luise Berres, Sven Papen, Katrin Pauels, et al.
Journal of Hepatology|November 15, 2017
Potentially inappropriate liver transplantation in the era of the "sickest first" policy - A search for the upper limitsMichael Linecker, Tanja Krones, Thomas Berg, et al.
Journal of Hepatology|October 7, 2004
Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infectionTobias Mueller, Andreas Mas-Marques, Christoph Sarrazin, et al.
Pageof 64

Showing results (321-330 of 632) with videos related to

Sort By:
Pageof 64
European Journal of Radiology|March 7, 2025
Hepatobiliary phase MRI-guided radiofrequency ablation of small hepatocellular carcinomas invisible on precontrast MRISebastian Ebel, Harald Busse, Anne Beeskow, et al.
Ultrasound in Medicine & Biology|May 4, 2026
Analysis of B-Scan Ultrasonography Using Neural Networks to Predict Risk of Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Josefine Stansch, Kien Vu Trung, Valentin Blank, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 16, 2003
CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophiliaHermann E Wasmuth, Alexa Werth, Tobias Mueller, et al.
The American Journal of Gastroenterology|June 28, 2019
Iberogast-Induced Acute Liver Failure-Reexposure and In Vitro Assay Support CausalityFlorian Gerhardt, Andreas Benesic, Hans L Tillmann, et al.
Journal of Gastroenterology|September 14, 2011
The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infectionViola Weich, Eva Herrmann, Tje Lin Chung, et al.
BMC Cancer|March 10, 2012
TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patientsChristian Körner, Katarina Riesner, Benjamin Krämer, et al.
Transplantation|October 5, 2002
Distinct enzyme profiles in patients with cryptogenic cirrhosis reflect heterogeneous causes with different outcomes after liver transplantation (OLT): a long-term documentation before and after OLTThomas Berg, Ruth Neuhaus, Reinhild Klein, et al.
Journal of Hepatology|December 17, 2008
A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infectionMarie-Luise Berres, Sven Papen, Katrin Pauels, et al.
Journal of Hepatology|November 15, 2017
Potentially inappropriate liver transplantation in the era of the "sickest first" policy - A search for the upper limitsMichael Linecker, Tanja Krones, Thomas Berg, et al.
Journal of Hepatology|October 7, 2004
Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infectionTobias Mueller, Andreas Mas-Marques, Christoph Sarrazin, et al.
Pageof 64